4 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow EDP-235: new trials by email Literature Review of EDP-235 trials Research Report on EDP-235
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19 EDP-235, Placebo - COVID-19 | Phase 2 | Completed | Enanta Pharmaceuticals, Inc | 231 | 2022-11-10 | 2024-08-19 |
| Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects EDP-235, Midazolam, Rosuvastatin - COVID-19 | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 24 | 2022-10-06 | 2023-04-27 |
| Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects. EDP-235, Itraconazole, Carbamazepine - COVID-19 | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 36 | 2022-10-06 | 2023-04-27 |
| A Study of EDP-235 in Healthy Subjects EDP-235, Placebo - SARS CoV 2 Infection | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 72 | 2022-01-28 | 2022-08-19 |
COVID-19 (4)
Enanta Pharmaceuticals, Inc (4)
United States (4) · Romania (1)